Skip to main content
. 2021 Jul 21;5(4):499–514. doi: 10.7150/ntno.62730

Figure 4.

Figure 4

Theranostic nanoparticles for thrombosis. (A) Schematic representation of an Fe3O4-PLGA-rtPA/CS-cRGD nanoparticle.79 (B) Schematic of the PPACK-functionalized PFC-core nanoparticle88 (C) Schematic illustration of T-FBM nanoparticles as a thrombus-specific nanotheranostic agent. T-FBM nanoparticles target a fibrin-rich thrombus and serve as a H2O2-triggered photoacoustic signal amplifier but also an antithrombotic nanomedicine.91